Clinical implications of expression of vascular endothelial growth factor in metastatic lesions of ovarian cancers

Br J Cancer. 2001 Aug 3;85(3):313-6. doi: 10.1054/bjoc.2001.1933.

Abstract

Vascular endothelial growth factor (VEGF) has been identified as an important factor for tumour angiogenesis, which is essential for the growth, invasion and metastasis of solid tumours. Significantly increased VEGF level from the primary tumour to the metastatic lesion of ovarian cancers was found in 8 of 30 cases. The 24-month survival rate of the patients with significantly increased VEGF level was extremely poor (0/8 = 0%) in comparison with that of patients with no change in the level (15/22 = 68%) from the primary tumour to the metastatic lesion. This indicates that VEGF may contribute to the advancement of metastatic lesions, and that VEGF level in metastatic lesions may be a prognostic indicator.

MeSH terms

  • Adult
  • Aged
  • Endothelial Growth Factors / metabolism*
  • Female
  • Humans
  • Immunoenzyme Techniques
  • Lymphokines / metabolism*
  • Middle Aged
  • Ovarian Neoplasms / metabolism*
  • Ovarian Neoplasms / mortality
  • Ovarian Neoplasms / pathology
  • Peritoneal Neoplasms / metabolism*
  • Peritoneal Neoplasms / mortality
  • Peritoneal Neoplasms / secondary
  • Prognosis
  • Survival Rate
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Lymphokines
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors